Pressmeddelande

Invitation to live presentation of Senzime’s first quarter 2024 report

Senzime invites investors, analysts, and media to a webcast presentation of the first quarter report for 2024 on May 7, 10:00 CEST. The report will be published during the morning of the same day.

The presentation will be held by Philip Siberg, CEO of Senzime, and after the presentation, there will be a Q&A session moderated by analyst at Carnegie Investment Bank. The presentation will be held in English.

Date and time: Tuesday, May 7, 10:00-10:30 am CEST

The presentation can be followed live via webcast at https://www.youtube.com/watch?v=TukFP5Laenw.

After the presentation, a recording of the webcast will be available at senzime.com/investors.

About Senzime

Senzime, headquartered in Sweden, is a leading medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. The company provides an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for accurate monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.

Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (Nasdaq: SEZI) and cross-traded in the US on the OTCQX market (OTCQX: SNZZF). More information is available at senzime.com.

Source:MFN

Tillbaka

Det verkar som att du använder en annonsblockerare

Logga in på di.se

Inte prenumerant än?

Tillgång till alla nyhetsbrev med en prenumeration